AccurKardia has gained the US Food and Drug Administration's (FDA) breakthrough device designation for its AI-powered ‘AK+ ...

AccurKardia announced that it received FDA breakthrough device designation for its ECG-based, AI-powered hyperkalemia ...

AccurKardia, an innovator in ECG-based diagnostics technology, has announced that it has received Breakthrough Device ...

Narrowing of this valve, known as aortic stenosis, impacts blood flow out of the heart. More than 13% of older adults have aortic stenosis. Aortic regurgitation, on the other hand, is leakiness of ...

Aortic valve stenosis (AVS) is a progressive disease characterized by fibrosis, inflammation, calcification, and stiffening of the aortic valve leaflets, leading to disrupted blood flow. If untreated, ...